OPM is a technological company specialized in precision medicine.
OPM's mission is to bring innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution. The patient is at the centre of our reflexion, of our unique innovative model, and our investments.
For OPM "our collective success is paramount", there can be no value creation without exchange, without dialogue. The value creation resulting for us from reciprocity, i.e. balanced and fair exchanges at all levels, whether between internal collaborators, or with our partners, therapists, patients, experts and investors.
2020
Served areaWorldwide
Headquarters18 rue Jean Mazen, 21000 Dijon – France
16,610,000
IPOOct. 5, 2022
Stock exchange(s)Euronext Paris
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.